Inhibrx Biosciences, Inc.

Home
United States
La Jolla, CA
Inhibrx Biosciences, Inc.

Directions Website

At Inhibrx, our mission is to deliver optimized, biologic therapeutics to people with life-threatening conditions.

10/05/2026

Our team came together onsite for Inhibrx Day, a chance to connect, share insights, and recognize the people behind our work.

We’re grateful for the collaboration, dedication, and passion each team member brings to Inhibrx.

Every day, our hard work and contributions help advance our mission of bringing hope and innovative treatment options to patients in need.

09/26/2026

Our commitment to advancing research in rare cancers extends to Ewing sarcoma.

At Inhibrx, we are actively investigating ozekibart (INBRX-109) in patients with Ewing sarcoma, with the goal of exploring potential new treatment options for this rare cancer.

Learn more about the study details and eligibility: https://tinyurl.com/6w46a4hm

09/24/2026

World Cancer Research Day highlights the continued importance of research in advancing our understanding of cancer and supporting scientific progress across oncology.

At Inhibrx, our research efforts draw on our understanding of target biology and protein-engineering to support the discovery and development of biologic therapeutics.

Learn more about our scientific approach: https://tinyurl.com/hbruccuh

09/12/2026

Inhibrx is proud to support the Northwest Sarcoma Foundation and join the 2026 Dragonslayer Fantasy Dash & Strut in Portland.

Today’s event brings together the sarcoma community for a day of connection and movement.

We’re grateful to take part alongside everyone supporting the sarcoma community.

09/10/2026

September is Childhood Cancer Awareness Month, a time to recognize children, adolescents, families, caregivers, and the broader community affected by childhood cancer.

Ewing sarcoma is a rare cancer most commonly diagnosed in adolescents and young adults, underscoring the continued importance of research to help address ongoing unmet needs.

Learn more about our ongoing research in Ewing sarcoma: https://tinyurl.com/6w46a4hm

09/08/2026

Inhibrx is excited to announce primary endpoint results for INBRX-106 from our Phase 2 first-line HNSCC study.

Read the full press release on our website: https://tinyurl.com/5e4x7fjp

09/02/2026

Ewing sarcoma is a rare and complex cancer that can present significant challenges for the people and families affected by the disease.

Continued research is an important part of building a greater understanding of Ewing sarcoma and addressing the unmet needs that remain across the patient journey.

Inhibrx continues to advance research in Ewing sarcoma through our work with ozekibart (INBRX-109).

Learn more about our ongoing research: https://tinyurl.com/6w46a4hm

08/15/2026

Ozekibart (INBRX-109) continues to be evaluated in an ongoing Phase 1/2 study that includes cohorts in Ewing sarcoma and colorectal adenocarcinoma.

Learn more about the current study cohorts and eligibility information: https://tinyurl.com/6w46a4hm

08/01/2026

World Lung Cancer Day brings attention to the people living with lung cancer and the continued need for progress in research and potential new treatment options.

For many patients, significant unmet needs remain. Our ongoing work with INBRX-106 includes research in Non-Small Cell Lung Cancer ( ) as part of our broader commitment to advancing oncology research.

Learn more about the INBRX-106 program: https://tinyurl.com/55whrp5m

07/27/2026

World Head and Neck Cancer Day highlights the importance of awareness, research, and progress for people affected by head and neck cancer.

This observance is also a reminder that significant unmet needs remain, underscoring the need for continued research and new treatment approaches.

Our ongoing research in head and neck cancer reflects a continued commitment to advancing work in this field.

Learn more about our research in head and neck cancer: https://tinyurl.com/55whrp5m

Address

Torrey Pines Science Park 11025 N Torrey Pines Road #200
La Jolla, CA
92037

Website

https://inhibrx.com/

Alerts

Be the first to know and let us send you an email when Inhibrx Biosciences, Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Want your business to be the top-listed business in La Jolla?